UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.

The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...

The Government is expected to perform a U-turn in the budget by scrapping plans to impose a capital gains tax (CGT) liability ...

Eli Lilly's valuation is a critical concern, but its robust execution has improved its ability to actualize its high-growth ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

The FTC said that insulin medication was previously more affordable, using the example of Humalog, a medication manufactured ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

During ESPN’s “ManningCast” of the Falcons-Eagles “Monday Night Football” game, Bill Belichick took a jab at his former team.

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...